17:50 , Nov 2, 2017 |  BC Innovations  |  Product R&D

Sweet specificity

Siamab Therapeutics Inc. is gearing up to compete in the small but active space of companies targeting sugar groups that are up-regulated in cancer. So far, its technology has produced a lead therapeutic, a deal...
07:00 , Oct 8, 2012 |  BC Week In Review  |  Company News

Momenta, Sialix deal

Sialix granted Momenta an option to license a preclinical mAb program against cancer-specific glycans containing non-human sialic acid N-glycolylneuraminic acid (Neu5Gc). Sialix declined to disclose details. Momenta could not be reached for details....
00:38 , Oct 6, 2012 |  BC Extra  |  Company News

Sialix in deal with Momenta

Sialix Inc. (Newton, Mass.) granted Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) an option to license a preclinical mAb program against cancer-specific glycans containing N-glycolylneuraminic acid (Neu5Gc). Sialix declined to disclose details. Momenta could not be reached for...
07:00 , Aug 5, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms Addition of N-acetylneuraminic acid (Neu5Ac) to culture media for producing recombinant therapeutic glycoproteins In vitro and mouse studies suggest...
08:00 , Jan 31, 2005 |  BC Week In Review  |  Company News

University of California, The Salk Institute for Biological Studies other research news

Researchers published in Nature Medicine that hESCs, including those approved under federal funding in the U.S., have been contaminated by a non-human, cell-surface sialic acid called N-glycolylneuraminic acid (Neu5Gc). Human cells are genetically unable to...
08:00 , Jan 24, 2005 |  BC Extra  |  Clinical News

Researchers find stem cells contaminated

Researchers published in Nature Medicine that currently available lines of human embryonic stem cells, including those approved under federal funding in the U.S., have been contaminated by a non-human, cell-surface sialic acid called N-glycolylneuraminic...